封面
市場調查報告書
商品編碼
1475904

神經血管血栓切除設備市場:依產品類型,最終用戶,地區-全球產業分析,規模,佔有率,成長,趨勢,預測2024-2031 年

Neurovascular Thrombectomy Devices Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

出版日期: | 出版商: Persistence Market Research | 英文 194 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

本報告詳細分析了全球神經血管血栓切除設備市場。它對市場趨勢、成長驅動因素/課題和新興機會進行了深入分析,為神經血管血栓切除術領域提供了寶貴的見解。它提供了對市場的詳細研究,並提供了繪製 2024 年至 2031 年市場軌蹟的關鍵統計數據和預測。

重要見解

  • 神經血管血栓切除裝置市場規模(2024年):7.417億美元
  • 市場預測(2031年):11.471億美元
  • 全球市場成長率(2024-2031年複合年增長率):6.42%

神經血管血栓切除設備市場 - 報告範圍:

神經血管血栓切除設備市場包括一系列用於治療大血管閉塞引起的急性缺血性中風的重要設備。這些設備包括支架回收器、抽吸導管和其他旨在恢復閉塞腦動脈血流的輔助設備。該市場為醫院、專科診所和門診手術中心提供先進的血栓清除解決方案,以改善患者的治療效果並減少與中風相關的殘疾。

市場驅動因素:

全球神經血管血栓切除設備市場由幾個關鍵成長因素推動。缺血性中風的盛行率不斷增加,以及人們對血管內血栓切除術益處的認識不斷提高,正在推動對先進神經血管設備的需求。血栓切除裝置的技術進步,例如下一代支架取栓器和抽吸系統的開發,將提高手術的有效性並擴大血管內治療的患者群體。此外,醫療設備製造商、神經科醫生和介入放射科醫生之間的合作正在推動血栓清除設備的創新和採用,從而促進市場成長。

市場限制因素:

儘管預計成長前景良好,但神經血管血栓切除設備市場面臨報銷政策、程序複雜性和醫生培訓方面的課題。血栓切除術的報銷範圍因醫療保健系統而異,影響設備採用率和醫院的投資決策,為市場擴張造成障礙。此外,執行神經介入手術所需的專業技能和基礎設施需要對醫療專業人員進行持續的培訓和教育,這限制了馬蘇地區血栓切除手術的廣泛普及。

市場機會:

在技術創新、臨床研究和醫療基礎設施發展的推動下,神經血管血栓切除設備市場提供了利潤豐厚的機會。遠端中風網絡、移動中風病房和院前中風分診方案等新興趨勢將提高及時血栓切除治療的可及性,並擴大神經血管設備的適用患者群體。此外,對人工智慧、機器人和數位健康解決方案的投資將能夠提供個人化的中風護理,促進精準醫療的方法和優化治療結果。此外,醫療器材公司、學術研究機構和監管機構之間的策略合作夥伴關係促進創新和監管合規,為市場成長和產品差異化鋪平道路。

本報告解決的關鍵問題

  • 推動神經血管血栓切除設備市場全球成長的關鍵因素是什麼?
  • 技術進步和臨床研究如何影響神經血管血栓切除設備和手術的發展?
  • 神經介入設備領域的市場進入者面臨哪些主要課題與機會?
  • 神經血管血栓切除裝置在哪些地區和醫療機構最有成長潛力?
  • 在神經血管介入的競爭格局中,領先公司採取哪些策略來提高產品創新、市場滲透率和臨床效果?

競爭資訊與經營策略:

全球神經血管血栓切除設備市場的主要參與者,包括跨國醫療器材公司、神經血管新創公司和學術研究機構,都專注於技術創新、臨床證據產生和市場拓展,以獲得競爭優勢。這些公司投資研發,創造符合臨床指引和病人偏好的新血栓清除設備、手術和中風治療途徑。此外,與中風中心、神經病學協會和醫療保健政策制定者的策略合作夥伴關係可以幫助設備製造商推進神經介入療法的臨床採用、報銷和監管批准。此外,對上市後監測、真實世界證據產生和患者報告結果的關注將促進神經血管血栓切除術動態領域的持續改進和基於價值的創新。

主要公司簡介

  • Medtronic Plc
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Johnson & Johnson Services, Inc.
  • Penumbra Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Acandis GmbH
  • Argon Medical Inc
  • 其他

神經血管血栓切除裝置市場細分

依產品

  • 支架回收器
  • 抽吸導管

依地區

  • 北美
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東/非洲

目錄

第一章內容提要

第二章 市場介紹

  • 市場分類
  • 市場定義
  • 依產品類型劃分的市場定義

第三章 世界經濟展望

  • 依地區和國家劃分的國內生產毛額產品類型(2006-2023)
  • 全球醫療保健市場指標

第四章市場機會分析

  • 宏觀經濟因素
  • 機會分析

第五章市場動態

  • 促進因素
  • 抑制因素
  • 機會
  • 趨勢

第六章宏觀經濟假設

第七章 重大綜合事項

  • 區域平均價格分析
  • 贖回場景
  • 主要規定

第8章北美神經血管血栓切除裝置市場分析(2019-2023)與預測(2024-2031)

第9章拉丁美洲神經血管血栓切除設備市場分析(2019-2023)與預測(2024-2031)

第10章歐洲神經血管血栓切除裝置市場分析(2019-2023)與預測(2024-2031)

第十一章 除中國以外的亞太地區神經血管血栓切除設備市場分析(2019-2023)和預測(2024-2031)

第十二章中國神經血管取栓設備市場分析(2019-2023)及預測(2024-2031)

  • 介紹
  • 過去的市場規模趨勢分析(2019-2023):依產品類型
    • 支架回收器
    • 抽吸導管
  • 市場規模預測(2024-2031):依產品類型
  • 過去的市場規模趨勢分析(2019-2023):依最終用戶
    • 醫院
    • 神經導管實驗室
    • 專科神經外科中心
  • 市場規模預測(2024-2031):依最終用戶劃分
  • 市場吸引力分析
  • 加速器和約束:影響分析

第十三章中東和非洲神經血管血栓切除裝置市場分析(2019-2023)和預測(2024-2031)

第 14 章預測因子:相關性與影響

第十五章預測的前提條件

第16章市場結構分析

  • 依層級劃分的市場結構

第 17 章 競爭分析

  • 比賽儀表板
  • 衝突詳情
    • Medtronic Plc
    • Stryker Corporation
    • Teleflex Incorporated
    • Terumo Corporation
    • Johnson & Johnson Services, Inc.
    • Penumbra Inc.
    • Boston Scientific Corporation
    • Edwards Lifesciences Corporation
    • Acandis GmbH
    • Argon Medical Inc

第十八章全球神經血管血栓切除設備市場分析(2019-2023)與預測(2024-2031):依地區

  • 簡介/主要發現
  • 過去的市場規模分析:依地區
    • 北美
    • 拉丁美洲
    • 歐洲
    • 亞太地區(不包括中國)
    • 中國
    • 中東/非洲
  • 市場規模預測:依地區
  • 依地區劃分的市場吸引力分析

第十九章全球神經血管血栓切除設備市場分析(2019-2023)與預測(2024-2031):依產品類型

  • 簡介/主要發現
  • 過去的市場規模分析(2019-2023):依產品類型
    • 支架回收器
    • 抽吸導管
  • 市場規模預測(2024-2031):依產品類型
  • 依產品類型分析市場吸引力

第20章全球神經血管血栓切除設備市場分析(2019-2023)與預測(2024-2031):依最終用戶

  • 簡介/主要發現
  • 過去的市場規模分析(2019-2023):依最終用戶
    • 醫院
    • 神經導管實驗室
    • 專科神經外科中心
  • 市場規模預測(2024-2031):依最終用戶劃分
  • 最終用戶的市場吸引力分析

第21章全球神經血管血栓切除設備市場分析(2019-2023)與機會評估(2024-2031)

  • 市場金額分析
  • 絕對數量機會

第22章假設和縮寫

第23章研究方法論

簡介目錄
Product Code: PMRREP26176

Persistence Market Research presents an in-depth analysis of the global Neurovascular Thrombectomy Devices Market. Offering an in-depth analysis of market trends, growth drivers, challenges, and emerging opportunities, this study provides valuable insights into the neurovascular thrombectomy sector. It offers a detailed examination of the market, furnishing crucial statistics and projections delineating the market's trajectory from 2024 to 2031.

Key Insights:

  • Neurovascular Thrombectomy Devices Market Size (2024): USD 741.7 Million
  • Projected Market Value (2031): USD 1147.1 Million
  • Global Market Growth Rate (CAGR 2024 to 2031): 6.42%

Neurovascular Thrombectomy Devices Market - Report Scope:

The Neurovascular Thrombectomy Devices Market encompasses a range of critical devices utilized in the treatment of acute ischemic stroke caused by large vessel occlusion. These devices include stent retrievers, aspiration catheters, and other adjunctive devices designed to restore blood flow in occluded cerebral arteries. The market serves hospitals, specialty clinics, and ambulatory surgical centers, offering advanced thrombectomy solutions to improve patient outcomes and reduce disability associated with stroke.

Market Growth Drivers:

The global Neurovascular Thrombectomy Devices Market is driven by several key growth factors. The increasing incidence of ischemic stroke, coupled with growing awareness about the benefits of endovascular thrombectomy procedures, fuels demand for advanced neurovascular devices. Technological advancements in thrombectomy devices, such as the development of next-generation stent retrievers and aspiration systems, enhance procedural efficacy and expand the eligible patient population for endovascular treatment. Moreover, collaborative efforts between medical device manufacturers, neurologists, and interventional radiologists drive innovation and adoption of thrombectomy devices, contributing to market growth.

Market Restraints:

Despite promising growth prospects, the Neurovascular Thrombectomy Devices Market faces challenges related to reimbursement policies, procedural complexities, and physician training. Variations in reimbursement coverage for thrombectomy procedures across different healthcare systems impact device adoption rates and hospital investment decisions, posing a barrier to market expansion. Furthermore, the specialized skills and infrastructure required for performing neurointerventional procedures necessitate ongoing training and education for healthcare professionals, limiting widespread access to thrombectomy services in certain regions.

Market Opportunities:

The Neurovascular Thrombectomy Devices Market presents lucrative opportunities driven by technological innovation, clinical research, and healthcare infrastructure development. Emerging trends such as telestroke networks, mobile stroke units, and prehospital stroke triage protocols enhance access to timely thrombectomy treatment, expanding the addressable patient population for neurovascular devices. Additionally, investments in artificial intelligence, robotics, and digital health solutions enable personalized stroke care delivery, facilitating precision medicine approaches and optimizing treatment outcomes. Moreover, strategic collaborations between medical device companies, academic research institutions, and regulatory agencies foster innovation and regulatory compliance, paving the way for market growth and product differentiation.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Neurovascular Thrombectomy Devices Market globally?
  • How are technological advancements and clinical research shaping the evolution of neurovascular thrombectomy devices and procedures?
  • What are the key challenges and opportunities facing market participants in the neurointerventional device segment?
  • Which geographic regions and healthcare settings offer the highest growth potential for neurovascular thrombectomy devices?
  • What strategies are leading companies employing to enhance product innovation, market penetration, and clinical outcomes in the competitive landscape of neurovascular interventions?

Competitive Intelligence and Business Strategy:

Leading players in the global Neurovascular Thrombectomy Devices Market, including multinational medical device companies, neurovascular startups, and academic research institutions, focus on innovation, clinical evidence generation, and market expansion to gain a competitive edge. These companies invest in research and development to create novel thrombectomy devices, procedural techniques, and stroke care pathways aligned with clinical guidelines and patient preferences. Moreover, strategic partnerships with stroke centers, neurological societies, and healthcare policymakers enable device manufacturers to drive clinical adoption, reimbursement advocacy, and regulatory approval for neurointerventional therapies. Furthermore, emphasis on post-market surveillance, real-world evidence generation, and patient-reported outcomes fosters continuous improvement and value-based innovation in the dynamic landscape of neurovascular thrombectom

Key Companies Profiled:

  • Medtronic Plc
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Johnson & Johnson Services, Inc.
  • Penumbra Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Acandis GmbH
  • Argon Medical Inc
  • Others.

Neurovascular Thrombectomy Devices Market Segmentation

By Product

  • Stent Retriever
  • Aspiration Catheter

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Taxonomy
  • 2.2. Market Definition
  • 2.3. Market Definition by Product Type

3. Global Economic Outlook

  • 3.1. Gross Domestic Product Type by Region & Country, 2006 - 2023
  • 3.2. Global Healthcare Market Indicators

4. Market Opportunity Analysis

  • 4.1. Macro-Economic Factors
  • 4.2. Opportunity Analysis

5. Market Dynamics

  • 5.1. Drivers
  • 5.2. Restraints
  • 5.3. Opportunities
  • 5.4. Trends

6. Macroeconomic Assumptions

7. Key Inclusion

  • 7.1. Regional Average Pricing Analysis
  • 7.2. Reimbursement Scenario
  • 7.3. Key Regulations

8. North America Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Mn) Analysis By Country, 2019-2023
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 8.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2019-2023
    • 8.4.1. Stent Retriever
    • 8.4.2. Aspiration Catheter
  • 8.5. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
  • 8.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019-2023
    • 8.6.1. Hospitals
    • 8.6.2. Neuro-Catheterization Labs
    • 8.6.3. Specialized Neurosurgery Centers
  • 8.7. Market Size (US$ Mn) Forecast By End User, 2024-2031
  • 8.8. Market Attractiveness Analysis
    • 8.8.1. By Country
    • 8.8.2. By Product Type
    • 8.8.3. By End User
  • 8.9. Drivers and Restraints: Impact Analysis

9. Latin America Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031

  • 9.1. Introduction
  • 9.2. Regional Market Trends
  • 9.3. Historical Market Size (US$ Mn) Analysis By Country, 2019-2023
    • 9.3.1. Brazil
    • 9.3.2. Mexico
    • 9.3.3. Rest of Latin America
  • 9.4. Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 9.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2019-2023
    • 9.5.1. Stent Retriever
    • 9.5.2. Aspiration Catheter
  • 9.6. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
  • 9.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019-2023
    • 9.7.1. Hospitals
    • 9.7.2. Neuro-Catheterization Labs
    • 9.7.3. Specialized Neurosurgery Centers
  • 9.8. Market Size (US$ Mn) Forecast By End User, 2024-2031
  • 9.9. Market Attractiveness Analysis
    • 9.9.1. By Country
    • 9.9.2. By Product Type
    • 9.9.3. By End User
  • 9.10. Drivers and Restraints: Impact Analysis

10. Europe Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis By Country, 2019-2023
    • 10.2.1. Germany
    • 10.2.2. U.K
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Russia
    • 10.2.7. Poland
    • 10.2.8. Rest of Western Europe
  • 10.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 10.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2019-2023
    • 10.4.1. Stent Retriever
    • 10.4.2. Aspiration Catheter
  • 10.5. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
  • 10.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019-2023
    • 10.6.1. Hospitals
    • 10.6.2. Neuro-Catheterization Labs
    • 10.6.3. Specialized Neurosurgery Centers
  • 10.7. Market Size (US$ Mn) Forecast By End User, 2024-2031
  • 10.8. Market Attractiveness Analysis
    • 10.8.1. By Country
    • 10.8.2. By Product Type
    • 10.8.3. By End User
  • 10.9. Drivers and Restraints: Impact Analysis

11. Asia Pacific Excluding China Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis By Country, 2019-2023
    • 11.2.1. Japan
    • 11.2.2. India
    • 11.2.3. Australia and New Zealand
    • 11.2.4. ASEAN
    • 11.2.5. Rest of Asia Pacific
  • 11.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 11.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2019-2023
    • 11.4.1. Stent Retriever
    • 11.4.2. Aspiration Catheter
  • 11.5. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
  • 11.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019-2023
    • 11.6.1. Hospitals
    • 11.6.2. Neuro-Catheterization Labs
    • 11.6.3. Specialized Neurosurgery Centers
  • 11.7. Market Size (US$ Mn) Forecast By End User, 2024-2031
  • 11.8. Market Attractiveness Analysis
    • 11.8.1. By Country
    • 11.8.2. By Product Type
    • 11.8.3. By End User
  • 11.9. Drivers and Restraints: Impact Analysis

12. China Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2019-2023
    • 12.2.1. Stent Retriever
    • 12.2.2. Aspiration Catheter
  • 12.3. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
  • 12.4. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019-2023
    • 12.4.1. Hospitals
    • 12.4.2. Neuro-Catheterization Labs
    • 12.4.3. Specialized Neurosurgery Centers
  • 12.5. Market Size (US$ Mn) Forecast By End User, 2024-2031
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By End User
  • 12.7. Drivers and Restraints: Impact Analysis

13. Middle East and Africa Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Country, 2019-2023
    • 13.2.1. GCC Countries
    • 13.2.2. South Africa
    • 13.2.3. Rest of Middle East and Africa
  • 13.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 13.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2019-2023
    • 13.4.1. Stent Retriever
    • 13.4.2. Aspiration Catheter
  • 13.5. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
  • 13.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019-2023
    • 13.6.1. Hospitals
    • 13.6.2. Neuro-Catheterization Labs
    • 13.6.3. Specialized Neurosurgery Centers
  • 13.7. Market Size (US$ Mn) Forecast By End User, 2024-2031
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Country
    • 13.8.2. By Product Type
    • 13.8.3. By End User
  • 13.9. Drivers and Restraints: Impact Analysis

14. Forecast Factors: Relevance and Impact

15. Forecast Assumptions

16. Market Structure Analysis

  • 16.1. Market Structure by Tier

17. Competition Analysis

  • 17.1. Competition Dashboard
  • 17.2. Competitors Deep Dive
    • 17.2.1. Medtronic Plc
      • 17.2.1.1. Overview
      • 17.2.1.2. Analyst Commentary
      • 17.2.1.3. Product Type and Technology Portfolio
      • 17.2.1.4. Channel Footprint
      • 17.2.1.5. Strategy
        • 17.2.1.5.1. Marketing Strategy
        • 17.2.1.5.2. Product Type Strategy
        • 17.2.1.5.3. Channel Strategy
    • 17.2.2. Stryker Corporation
      • 17.2.2.1. Overview
      • 17.2.2.2. Analyst Commentary
      • 17.2.2.3. Product Type and Technology Portfolio
      • 17.2.2.4. Channel Footprint
      • 17.2.2.5. Strategy
        • 17.2.2.5.1. Marketing Strategy
        • 17.2.2.5.2. Product Type Strategy
        • 17.2.2.5.3. Channel Strategy
    • 17.2.3. Teleflex Incorporated
      • 17.2.3.1. Overview
      • 17.2.3.2. Analyst Commentary
      • 17.2.3.3. Product Type and Technology Portfolio
      • 17.2.3.4. Channel Footprint
      • 17.2.3.5. Strategy
        • 17.2.3.5.1. Marketing Strategy
        • 17.2.3.5.2. Product Type Strategy
        • 17.2.3.5.3. Channel Strategy
    • 17.2.4. Terumo Corporation
      • 17.2.4.1. Overview
      • 17.2.4.2. Analyst Commentary
      • 17.2.4.3. Product Type and Technology Portfolio
      • 17.2.4.4. Channel Footprint
      • 17.2.4.5. Strategy
        • 17.2.4.5.1. Marketing Strategy
        • 17.2.4.5.2. Product Type Strategy
        • 17.2.4.5.3. Channel Strategy
    • 17.2.5. Johnson & Johnson Services, Inc.
      • 17.2.5.1. Overview
      • 17.2.5.2. Analyst Commentary
      • 17.2.5.3. Product Type and Technology Portfolio
      • 17.2.5.4. Channel Footprint
      • 17.2.5.5. Strategy
        • 17.2.5.5.1. Marketing Strategy
        • 17.2.5.5.2. Product Type Strategy
        • 17.2.5.5.3. Channel Strategy
    • 17.2.6. Penumbra Inc.
      • 17.2.6.1. Overview
      • 17.2.6.2. Analyst Commentary
      • 17.2.6.3. Product Type and Technology Portfolio
      • 17.2.6.4. Channel Footprint
      • 17.2.6.5. Strategy
        • 17.2.6.5.1. Marketing Strategy
        • 17.2.6.5.2. Product Type Strategy
        • 17.2.6.5.3. Channel Strategy
    • 17.2.7. Boston Scientific Corporation
      • 17.2.7.1. Overview
      • 17.2.7.2. Analyst Commentary
      • 17.2.7.3. Product Type and Technology Portfolio
      • 17.2.7.4. Channel Footprint
      • 17.2.7.5. Strategy
        • 17.2.7.5.1. Marketing Strategy
        • 17.2.7.5.2. Product Type Strategy
        • 17.2.7.5.3. Channel Strategy
    • 17.2.8. Edwards Lifesciences Corporation
      • 17.2.8.1. Overview
      • 17.2.8.2. Analyst Commentary
      • 17.2.8.3. Product Type and Technology Portfolio
      • 17.2.8.4. Channel Footprint
      • 17.2.8.5. Strategy
        • 17.2.8.5.1. Marketing Strategy
        • 17.2.8.5.2. Product Type Strategy
        • 17.2.8.5.3. Channel Strategy
    • 17.2.9. Acandis GmbH
      • 17.2.9.1. Overview
      • 17.2.9.2. Analyst Commentary
      • 17.2.9.3. Product Type and Technology Portfolio
      • 17.2.9.4. Channel Footprint
      • 17.2.9.5. Strategy
        • 17.2.9.5.1. Marketing Strategy
        • 17.2.9.5.2. Product Type Strategy
        • 17.2.9.5.3. Channel Strategy
    • 17.2.10. Argon Medical Inc
      • 17.2.10.1. Overview
      • 17.2.10.2. Analyst Commentary
      • 17.2.10.3. Product Type and Technology Portfolio
      • 17.2.10.4. Channel Footprint
      • 17.2.10.5. Strategy
        • 17.2.10.5.1. Marketing Strategy
        • 17.2.10.5.2. Product Type Strategy
        • 17.2.10.5.3. Channel Strategy

18. Global Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031 By Region

  • 18.1. Introduction / Key Findings
  • 18.2. Historical Market Size (US$ Mn) Analysis By Region
    • 18.2.1. North America
    • 18.2.2. Latin America
    • 18.2.3. Europe
    • 18.2.4. Asia Pacific Excluding China
    • 18.2.5. China
    • 18.2.6. Middle East and Africa
  • 18.3. Market Size (US$ Mn) Forecast By Region
  • 18.4. Market Attractiveness Analysis By Region

19. Global Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031, By Product Type

  • 19.1. Introduction/Key Finding
  • 19.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2019-2023
    • 19.2.1. Stent Retriever
    • 19.2.2. Aspiration Catheter
  • 19.3. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
  • 19.4. Market Attractiveness Analysis By Product Type

20. Global Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031, By End User

  • 20.1. Introduction/Key Finding
  • 20.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
    • 20.2.1. Hospitals
    • 20.2.2. Neuro-Catheterization Labs
    • 20.2.3. Specialized Neurosurgery Centers
  • 20.3. Market Size (US$ Mn) Forecast By End User, 2024-2031
  • 20.4. Market Attractiveness Analysis By End User

21. Global Neurovascular Thrombectomy Devices Market Analysis 2019-2023 and Opportunity Assessment, 2024-2031

  • 21.1. Market Value Analysis (US$ Mn)
  • 21.2. Absolute $ Opportunity

22. Assumptions and Acronyms Used

23. Research Methodology